ARS Pharmaceuticals, Inc. Related Party Transaction, Expenses from Transactions with Related Party
ARS Pharmaceuticals, Inc. (SPRY) reported Related Party Transaction, Expenses from Transactions with Related Party of $484.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2023-08-10
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2023-06-30 was $484.00K, a 15.38% decline year-over-year.
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2023-03-31 was $591.00K, a 9.44% increase year-over-year.
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-06-30 was $572.00K.
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-03-31 was $540.00K.
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for fiscal 2022 was $2.14M, a 100.00% increase from fiscal 2021.
- ARS Pharmaceuticals, Inc. related party transaction, expenses from transactions with related party for fiscal 2021 was $1.07M.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|
| 2023-06-30 | $484.00K 10-Q · filed 2023-08-10 | $1.07M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $591.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | $2.14M 10-K · filed 2023-03-23 | ||
| 2022-06-30 | $572.00K 10-Q · filed 2023-08-10 | $1.11M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $540.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $1.07M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |